Sun Pharma Strikes $11.8 Billion Deal to Buy Organon
Sun Pharmaceutical Industries has announced that it will acquire Organon & Co., a deal that will cost around $11.75 billion in total cash, which includes the amount to pay off Organon’s debt obligation. Under this agreement, Sun Pharma will be paying $14 per share in order to acquire all of Organon’s stock. This amount is…
Himanshu
Sun Pharma to Acquire US-Based Checkpoint TherapeuticsÂ
India’s leading pharmaceutical company, Sun Pharmaceutical Industries, has announced the acquisition of Checkpoint Therapeutics, a U.S.-based biotechnology firm specialising in oncology. The deal is set to expand Sun Pharma’s oncology portfolio and strengthen its global presence in the rapidly growing cancer treatment market. Last year, the company signed a licensing agreement with Italian-Swiss firm Philogen…
Abdullah Ansari